ExpreS2ion Biotech (Sweden) Probability of Future Stock Price Finishing Over 20.9
| EXPRS2 Stock | SEK 19.24 0.66 3.32% |
ExpreS2ion |
ExpreS2ion Biotech Target Price Odds to finish over 20.9
The tendency of ExpreS2ion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over kr 20.90 or more in 90 days |
| 19.24 | 90 days | 20.90 | about 97.0 |
Based on a normal probability distribution, the odds of ExpreS2ion Biotech to move over kr 20.90 or more in 90 days from now is about 97.0 (This ExpreS2ion Biotech Holding probability density function shows the probability of ExpreS2ion Stock to fall within a particular range of prices over 90 days) . Probability of ExpreS2ion Biotech price to stay between its current price of kr 19.24 and kr 20.90 at the end of the 90-day period is about 1.15 .
Assuming the 90 days trading horizon ExpreS2ion Biotech Holding has a beta of -0.67 suggesting as returns on the benchmark increase, returns on holding ExpreS2ion Biotech are expected to decrease at a much lower rate. During a bear market, however, ExpreS2ion Biotech Holding is likely to outperform the market. Additionally ExpreS2ion Biotech Holding has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ExpreS2ion Biotech Price Density |
| Price |
Predictive Modules for ExpreS2ion Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ExpreS2ion Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ExpreS2ion Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ExpreS2ion Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ExpreS2ion Biotech is not an exception. The market had few large corrections towards the ExpreS2ion Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ExpreS2ion Biotech Holding, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ExpreS2ion Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.73 | |
β | Beta against Dow Jones | -0.67 | |
σ | Overall volatility | 6.62 | |
Ir | Information ratio | -0.13 |
ExpreS2ion Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ExpreS2ion Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ExpreS2ion Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ExpreS2ion Biotech generated a negative expected return over the last 90 days | |
| ExpreS2ion Biotech has high historical volatility and very poor performance | |
| The company reported the revenue of 12.23 M. Net Loss for the year was (43.92 M) with profit before overhead, payroll, taxes, and interest of 1.07 M. | |
| ExpreS2ion Biotech Holding has accumulated about 10.14 M in cash with (45.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. |
ExpreS2ion Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ExpreS2ion Stock often depends not only on the future outlook of the current and potential ExpreS2ion Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ExpreS2ion Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.9 M | |
| Cash And Short Term Investments | 138.9 M |
ExpreS2ion Biotech Technical Analysis
ExpreS2ion Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. ExpreS2ion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ExpreS2ion Biotech Holding. In general, you should focus on analyzing ExpreS2ion Stock price patterns and their correlations with different microeconomic environments and drivers.
ExpreS2ion Biotech Predictive Forecast Models
ExpreS2ion Biotech's time-series forecasting models is one of many ExpreS2ion Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ExpreS2ion Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ExpreS2ion Biotech
Checking the ongoing alerts about ExpreS2ion Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ExpreS2ion Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ExpreS2ion Biotech generated a negative expected return over the last 90 days | |
| ExpreS2ion Biotech has high historical volatility and very poor performance | |
| The company reported the revenue of 12.23 M. Net Loss for the year was (43.92 M) with profit before overhead, payroll, taxes, and interest of 1.07 M. | |
| ExpreS2ion Biotech Holding has accumulated about 10.14 M in cash with (45.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. |
Other Information on Investing in ExpreS2ion Stock
ExpreS2ion Biotech financial ratios help investors to determine whether ExpreS2ion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ExpreS2ion with respect to the benefits of owning ExpreS2ion Biotech security.